2025-12-23 - Analysis Report
Okay, here's a comprehensive report on Hims & Hers Health Inc. (HIMS), incorporating all the data provided and focusing on simple explanations followed by analysis.

**1. Return Rate Comparison:**

*   **Ticker:** HIMS
*   **Company Overview:** Hims & Hers Health Inc. is a telehealth company that provides personalized health and wellness solutions directly to consumers.
*   **HIMS Cumulative Return:** 129.58%
*   **VOO (S&P 500) Cumulative Return:** 74.84%
*   **Divergence:**
    *   **Current:** 54.7
    *   **Relative Divergence:** 34.5

**Analysis:** HIMS has significantly outperformed the S&P 500 (VOO) over the analyzed period.  The current divergence of 54.7 indicates a substantial difference in cumulative returns. The relative divergence of 34.5 suggests that the outperformance isn't at the very peak of its historical range but still represents a noteworthy positive deviation.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta   | Cap(B) |
|------------|---------|-------|---------|--------|--------|
| 2019-2021  | -42.0%  | 74.4% | -81.0%  | 0.0    | 1.5    |
| 2020-2022  | -19.0%  | 78.6% | -18.0%  | -0.0   | 1.4    |
| 2021-2023  | -65.0%  | 78.6% | -67.0%  | -0.1   | 2.0    |
| 2022-2024  | 119.0%  | 79.4% | 98.0%   | -0.0   | 5.4    |
| 2023-2025  | 134.0%  | 80.8% | 69.0%   | 0.1    | 8.0    |

**Analysis:**

*   **CAGR:**  The Compound Annual Growth Rate shows a wide range, with significant negative returns in earlier periods and very strong positive returns more recently.  This indicates high volatility and recent rapid growth.
*   **MDD:** The Maximum Drawdown is consistently high, indicating significant potential for losses from peak to trough.
*   **Alpha:** Alpha generally represents the excess return compared to the benchmark after accounting for risk.  The negative alpha in earlier periods suggests underperformance relative to the benchmark, while the strong positive alpha in recent periods indicates significant outperformance.
*   **Beta:** Beta measures the stock's volatility relative to the market.  A Beta around 0.0 suggests that HIMS' price movements are not strongly correlated with the overall market (S&P 500).
*   **Cap(B):** The market capitalization has grown significantly, reflecting investor confidence and company growth.

**2. Recent Stock Price Fluctuations:**

*   **Current Close:** 35.56
*   **Last Market Data:**
    *   **Price:** 35.05
    *   **Previous Close:** 35.56
    *   **Change:** -1.43%
*   **5-day SMA:** 35.682
*   **20-day SMA:** 37.355
*   **60-day SMA:** 44.5621

**Analysis:** The stock price is currently below both its 5-day and 20-day Simple Moving Averages (SMAs), suggesting a short-term downward trend. The 20-day SMA is also below the 60-day SMA, reinforcing this indication of downward momentum. The slight negative change in the last market indicates a slight decline and there is possibility of sharp rebound, sharp decline because the change is large.

**3. Indicators Analysis:**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 44.6
*   **PPO:** 0.0229
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (27 shares - Very Safe - MRI:0.90) Monthly invest 1.3% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** -2.7 (Negative - Short-term decline)
*   **Expected Return (%):** 31.3%

**Analysis:**

*   **MRI:** The MRI suggests a medium level of investment risk.
*   **RSI:** The RSI (Relative Strength Index) of 44.6 suggests the stock is neither overbought nor oversold.
*   **PPO:** The PPO (Percentage Price Oscillator) of 0.0229 close to 0, indicating that HIMS doesn't have significant upward momentum.
*   **Hybrid Signal:** The hybrid signal is Very Safe, so the return will be stable.
*   **Delta_Previous_Relative_Divergence:** The recent decrease in relative divergence suggests a short-term underperformance compared to its historical trend.
*   **Expected Return:** The 31.3% expected return is attractive and suggests potential for long-term growth.

**4. Recent News & Significant Events:**

*   **$250 Million Share Repurchase Program:**  This is generally positive as it can boost the stock price and signal management's confidence in the company.
*   **Seeking Alpha Article - "The Market's Panic Is Irrational":** This suggests potential undervaluation due to market overreaction, which could present a buying opportunity.
*   **Quiver Quantitative - "Opinions on Recent Volatility and Expansion":**  Highlights recent volatility and expansion, indicating potential for both risk and reward.
*   **Yahoo Finance - "Taking Stock of Valuation After a Sharp 90-Day Pullback":** Signals recent price decreases and suggests a focus on re-evaluating the company's value.
*   **MarketBeat - "Michael Chi Sells Shares":** Insider selling can be a negative signal but needs to be considered in context of the individual's holdings and overall transactions.
*   **Investing.com - "BofA Securities maintains underperform rating":** This is a negative signal.

**Analysis of News:** The news is mixed. The share repurchase and articles suggesting undervaluation are positive. However, the insider selling and BofA's "underperform" rating are concerning. The volatility and pullback highlight the need for careful risk assessment.

**4-2. Analyst Opinions:**

*   **Consensus:** Hold (2.93)
*   **Opinions:** 12
*   **Target Price (avg/high/low):** 44.67 / 85.00 / 25.00
*   **Recent Rating Changes:** No information

**Analysis:** The "Hold" consensus suggests analysts are generally neutral on the stock.  The average target price of $44.67 indicates potential upside from the current price, but the wide range (25-85) reflects uncertainty.

**5. Recent Earnings Analysis:**

| 날짜       | EPS   | 매출     |
|------------|-------|----------|
| 2025-11-03 | 0.07  | 0.60 B$ |
| 2025-08-04 | 0.19  | 0.54 B$ |
| 2025-05-05 | 0.22  | 0.59 B$ |
| 2024-11-04 | 0.35  | 0.40 B$ |
| 2025-11-03 | 0.35  | 0.40 B$ |

**Analysis:**

*   **EPS:**  The Earnings Per Share (EPS) is generally positive.
*   **Revenue:** Revenue shows an upward trend.
*   **Note**  : There are duplicated values on the table

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-09-30 | $0.60B    | 73.80%        |
| 2025-06-30 | $0.54B    | 76.39%        |
| 2025-03-31 | $0.59B    | 73.50%        |
| 2024-12-31 | $0.48B    | 76.81%        |
| 2024-09-30 | $0.40B    | 79.16%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE      |
|------------|-----------|----------|
| 2025-09-30 | $0.58B    | 2.72%    |
| 2025-06-30 | $0.56B    | 7.55%    |
| 2025-03-31 | $0.55B    | 9.01%    |
| 2024-12-31 | $0.48B    | 5.46%    |
| 2024-09-30 | $0.44B    | 17.18%   |

**Analysis:**

*   **Revenue:** Revenue is consistently increasing.
*   **Profit Margin:**  Profit margins are very high, indicating strong pricing power and efficient operations.
*   **Equity:** Equity is growing, which is a positive sign of financial health.
*   **ROE:** The Return on Equity (ROE) fluctuates.

**7. Comprehensive Analysis (Summary):**

*   **Overall:** HIMS has shown strong outperformance against the S&P 500, driven by recent rapid growth.  The company has high profit margins and increasing revenue.
*   **Risks:** The stock exhibits high volatility (high MDD). Recent price action is showing a short-term downtrend. Analyst opinions are mixed, with a "Hold" consensus but a wide range of target prices. There is a recent "underperform" rating from BofA. Insider selling raises some concern.
*   **Opportunities:** The share repurchase program, potential undervaluation (as suggested by Seeking Alpha), and the high expected return (31.3%) suggest potential upside. The positive revenue trend is encouraging.
*   **Recommendation:**  Given the high volatility and mixed signals, HIMS appears to be a higher-risk, higher-reward investment.  Careful consideration of risk tolerance and a thorough understanding of the company's business model are essential before investing. Investors should closely monitor news and analyst reports.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.